Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.
about
Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safetySafety of extended treatment with anakinra in patients with rheumatoid arthritisThe triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytesDermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.Advances in the treatment of cervical rheumatoid: Less surgery and less morbidityNew insights into the impact of neuro-inflammation in rheumatoid arthritisRheumatoid arthritis: a role for immunosenescence?Vaccination recommendations for adult patients with rheumatic diseasesTargeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic DrugsWhat is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trialsAdalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the LiteratureInfections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies.Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims databaseInfluenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis.Prosthetic joint infection in patients with rheumatoid arthritis: an outcome analysis compared with controls.Sporotrichal Tenosynovitis Diagnosed Helpfully by Musculoskeletal Ultrasonography.An audit of influenza and pneumococcal vaccination in rheumatology outpatients.Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapiesDefective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis.Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritisWhy do people with rheumatoid arthritis still die prematurely?Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritisTNF-α Antagonist and Infection in Rheumatoid Arthritis.Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.Initiation of rheumatoid arthritis treatments and the risk of serious infections.[Factors associated with infection in rheumatoid arthritis].Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women.Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases.Non-infectious pulmonary toxicity of rituximab: a systematic review.Vaccinations in patients with immune-mediated inflammatory diseases
P2860
Q24673716-47684DBD-7D99-40AB-873B-58BCFB6F3247Q24675209-0B77DDD8-5007-4F12-8847-4C2FDEA840F9Q24797661-8AD4A3E8-CBEE-43A2-AB0B-44A8E56F5FBEQ24816844-307BB6EA-EF30-4B3A-BC28-CC6B67D4B6FFQ26825270-448C0D17-001F-49B6-806D-07C5FC8725B8Q27023946-FAC541C1-32AC-4BC0-B0AC-C2053A89C4ADQ27693905-EA7D5923-DDBC-4815-B4D5-0723600F958FQ28068286-21D1C43B-3DEA-442E-9D37-C86B9C252A6DQ28073436-F185F92C-3D87-44BF-87E5-C806330BA588Q28074148-F7840A9D-6B70-4E5E-BBAE-15600D51EF8DQ28085725-11379D15-DCB5-429B-9D6F-DA20C413182BQ30047634-D25BD3E0-D276-46CD-8AD3-FBD6309AC0F1Q30245503-F77FB172-9E92-428F-AE13-E1F26FCFE693Q30360610-41E13FEA-41B0-4B9B-8039-BB28F91A38C8Q30397819-A174D400-BD20-43A9-A8EF-1092A617FB97Q30401020-6C03650B-1CBC-4D77-A2F1-CBAB6B759EDFQ30990764-01C6D3D9-4EFC-414A-B38C-D38C31096A4CQ31081624-3EC561CD-0E2D-4D5D-9B3B-B630CF4D6567Q31111950-F197FCC5-9A28-4DB5-8FA7-05F42195008FQ31131566-F1204BDE-780B-4042-B705-50C8CC1120E0Q32182031-D65FD7CC-9485-4EF2-A96B-0F68A0F6BFB5Q33289919-427D93B7-5EE3-4CF4-805A-E5261DD29AE3Q33315300-7B2F312E-79AE-4F18-96CA-1EDBBCB3C7C9Q33446433-FF0757F7-57EB-4297-95A2-7BE4C172BBC9Q33629320-E808796C-669F-4F54-BB4A-D720619CD1A7Q33646411-C0B08B3E-5DAC-4E49-8637-FBF44C3630FCQ33686087-CA61F92F-5B64-4B7B-BD68-4FDB8F44A6D4Q33697879-E4B7D4DB-A647-43D2-929F-5A4B864C8D38Q33778719-7A1E09D3-FB4E-4ABD-997F-F7BD8FE81B16Q33795738-3830390B-B6BE-4A54-89E6-0E787C5F76BFQ33819684-4D2308B3-19AB-4DD9-9301-938DA95606F7Q33841390-57949EDD-5957-408C-ACAA-9CAC5DDED3EDQ33872130-E11AB69B-B2AA-494F-86C8-0A8E5400301DQ33923452-4A89D135-4303-46C7-AA4F-800D89AD3CB2Q34019267-C0CDE4F4-2E44-4FEF-9965-B50E1CF47F7BQ34019646-DFD8E2FD-3A04-487B-8DB7-2449934015FAQ34056227-769FE9B2-9220-4327-BA86-D0B93E5BAC44Q34065002-9B441738-6E9D-44B2-AE9D-93AB0D911323Q34096300-FA81FD83-3AEC-4452-952F-6982FA48FF1DQ34117134-C6E4F6F3-7789-4636-A68D-2BE111EFC142
P2860
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Frequency of infection in pati ...... ols: a population-based study.
@ast
Frequency of infection in pati ...... ols: a population-based study.
@en
Frequency of infection in pati ...... ols: a population-based study.
@nl
type
label
Frequency of infection in pati ...... ols: a population-based study.
@ast
Frequency of infection in pati ...... ols: a population-based study.
@en
Frequency of infection in pati ...... ols: a population-based study.
@nl
prefLabel
Frequency of infection in pati ...... ols: a population-based study.
@ast
Frequency of infection in pati ...... ols: a population-based study.
@en
Frequency of infection in pati ...... ols: a population-based study.
@nl
P2093
P2860
P356
P1476
Frequency of infection in pati ...... ols: a population-based study.
@en
P2093
Cynthia S Crowson
Gregory R Pond
Michele F Doran
Sherine E Gabriel
W Michael O'Fallon
P2860
P304
P356
10.1002/ART.10524
P577
2002-09-01T00:00:00Z